- Joined
- Mar 15, 2011
- Messages
- 1,235
- Reaction score
- 120
Last weeks NEJM
Oral Apixiban for the treatment of acute venous thromboembolism.
5,000+ pts. Noninferior efficacy. Less major bleeding. Less minor bleeding.
How does this fit into your guys thinking in our previous rivarox vs warfarin debates.
I also read a a study showing a trend towards an all cause mortality reduction in addition to stroke prophylaxis superiority with apixiban compared with warfarin in AF therapy, looking for it now.
Oral Apixiban for the treatment of acute venous thromboembolism.
5,000+ pts. Noninferior efficacy. Less major bleeding. Less minor bleeding.
How does this fit into your guys thinking in our previous rivarox vs warfarin debates.
I also read a a study showing a trend towards an all cause mortality reduction in addition to stroke prophylaxis superiority with apixiban compared with warfarin in AF therapy, looking for it now.